LASA SUPERGENERICS
Back to Cashflow Statement
|
LASA SUPERGENERICS Last 5 Year Cash Flow from Financing Activities History
[Standalone]
| Mar2024 | Mar2023 | Mar2022 | Mar2021 | Mar2020 | |
|---|---|---|---|---|---|
| Cash Flow from Financing Activities | ₹-1.93 Cr | ₹-4.16 Cr | ₹-0.04 Cr | ₹-36 Cr | ₹-9.85 Cr |
What is the latest Cash Flow from Financing Activities ratio of LASA SUPERGENERICS ?
| Year | Cash Flow from Financing Activities |
|---|---|
| Mar2024 | ₹-1.93 Cr |
| Mar2023 | ₹-4.16 Cr |
| Mar2022 | ₹-0.04 Cr |
| Mar2021 | ₹-36 Cr |
| Mar2020 | ₹-9.85 Cr |
How is Cash Flow from Financing Activities of LASA SUPERGENERICS Trending?
| Years | Cash Flow from Financing Activities | % Change | |
|---|---|---|---|
| Mar2024 | ₹-1.93 Cr | Negative | |
| Mar2023 | ₹-4.16 Cr | Negative | |
| Mar2022 | ₹-0.04 Cr | Negative | |
| Mar2021 | ₹-36 Cr | Negative | |
| Mar2020 | ₹-9.85 Cr | - | |
Compare Cash Flow from Financing Activities of peers of LASA SUPERGENERICS
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| LASA SUPERGENERICS | ₹52.1 Cr | -9.9% | 12.2% | -59.7% | Stock Analytics | |
| SUN PHARMACEUTICAL INDUSTRIES | ₹416,728.0 Cr | -1.3% | -3.9% | -5.8% | Stock Analytics | |
| DIVIS LABORATORIES | ₹172,248.0 Cr | -2.3% | 0.9% | 12.9% | Stock Analytics | |
| TORRENT PHARMACEUTICALS | ₹133,627.0 Cr | 0.3% | 3.9% | 19.2% | Stock Analytics | |
| CIPLA | ₹118,423.0 Cr | -4.2% | -3.1% | -1.9% | Stock Analytics | |
| DR REDDYS LABORATORIES | ₹101,462.0 Cr | -3.2% | -4.5% | -11.8% | Stock Analytics | |
LASA SUPERGENERICS Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| LASA SUPERGENERICS | -9.9% |
12.2% |
-59.7% |
| SENSEX | -1.8% |
-0.6% |
7.3% |
You may also like the below Video Courses